These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Biomarkers in Parkinson's disease (recent update). Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710 [TBL] [Abstract][Full Text] [Related]
8. Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients. Winogrodzka A; Wagenaar RC; Bergmans P; Vellinga A; Booij J; van Royen EA; van Emmerik RE; Stoof JC; Wolters EC Mov Disord; 2001 Nov; 16(6):1033-40. PubMed ID: 11748734 [TBL] [Abstract][Full Text] [Related]
9. Research progress in the early diagnosis of Parkinson's disease. Xie L; Hu L Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779 [TBL] [Abstract][Full Text] [Related]
10. Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor. Wang XX; Feng Y; Li X; Zhu XY; Truong D; Ondo WG; Wu YC Front Neurol; 2020; 11():874. PubMed ID: 32982913 [No Abstract] [Full Text] [Related]
12. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease. Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404 [TBL] [Abstract][Full Text] [Related]
13. Translational molecular imaging and drug development in Parkinson's disease. Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912 [TBL] [Abstract][Full Text] [Related]
14. Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease. Martín-Bastida A; Delgado-Alvarado M; Navalpotro-Gómez I; Rodríguez-Oroz MC Front Neurol; 2021; 12():733570. PubMed ID: 34803882 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography neuroimaging in Parkinson's disease. Loane C; Politis M Am J Transl Res; 2011 Aug; 3(4):323-41. PubMed ID: 21904653 [TBL] [Abstract][Full Text] [Related]
16. The role of neuroimaging in Parkinson's disease. Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856 [TBL] [Abstract][Full Text] [Related]